May 10, 2021 09:00AM
Sep 25, 2020 09:00AM
Sep 9, 2020 09:39AM
Aug 27, 2020 08:00AM
Aug 26, 2020 09:15AM
Aug 25, 2020 03:10PM
Aug 25, 2020 12:19PM Generex Biotechnology Announces Call-in Details and Updated Agenda for Shareholder Conference Call on Wednesday August 26th, 2020 at 9:30 AM
Aug 19, 2020 09:00AM
Aug 17, 2020 09:00AM
Aug 13, 2020 09:30AM
Aug 4, 2020 09:00AM
Aug 3, 2020 09:00AM
Jul 1, 2020 09:00AM
Jun 26, 2020 09:00AM NuGenerex Immuno-Oncology Announces Shareholder Conference Call July 10, 2020 at 4:15 PM
Mar 30, 2020 10:00AM
Mar 12, 2020 01:13PM
Feb 24, 2020 09:21AM
Feb 12, 2020 09:00AM
Feb 10, 2020 09:00AM
Feb 4, 2020 09:56AM
Feb 4, 2020 09:56AM Generex Biotechnology Subsidiary Olaregen Therapeutix Receives VAC Approval and Ships Excellagen® to the Arizona Indian Health Service
Jan 24, 2020 09:00AM
Jan 17, 2020 02:08PM
Jan 17, 2020 09:00AM
Jan 16, 2020 12:28PM
Jan 15, 2020 03:16PM
Jan 13, 2020 12:28PM
Dec 10, 2019 09:30AM Generex Biotechnology Announces New Structure, Pay Date and Ex-Date for the Previously Postponed Shareholder Stock Dividend and Declares a New Share Dividend in NuGenerex Immuno-Oncology
Dec 5, 2019 10:29AM
Nov 27, 2019 11:10AM
Nov 25, 2019 08:30AM
Nov 13, 2019 02:03PM
Nov 8, 2019 09:48AM
Nov 5, 2019 09:15AM
Oct 29, 2019 08:30AM Generex Biotechnology Announces Extension to the Pay Date for the Previously Declared 1:1 Stock Dividend
Oct 28, 2019 09:56AM
Oct 25, 2019 02:06PM
Oct 25, 2019 11:00AM
Oct 18, 2019 09:15AM
Oct 15, 2019 09:00AM
Oct 14, 2019 09:30AM
Oct 10, 2019 09:15AM Generex Biotechnology Announces that Excellagen® Inventor, Dr. Lois Chandler will Present Clinical Data on Rapid Healing of Diabetic Foot Ulcers at The Symposium on Advanced Wound Care (SAWC) Fall Me
Oct 1, 2019 12:40PM
Oct 1, 2019 09:15AM
Sep 30, 2019 09:49AM
Sep 27, 2019 09:00AM
Sep 20, 2019 11:03AM
Sep 17, 2019 09:00AM
Sep 16, 2019 02:51PM Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete
Sep 12, 2019 12:20PM

1,157,576 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All